World of DTC Marketing

JUNE 20, 2022

Most of the media stories, however, leave out the possible drug side effects, which are serious. Will the target audience see this drug as a solution to losing weight and minimizing side effects? Whose responsibility is it to remind patients of the drug’s side effects?

Pharma 210

Pharma Side effects Media Marketing 210

Pharmaceutical Technology

FEBRUARY 13, 2024

The MHRA kicks off phase two of the Yellow Card biobank to explore the genetic link to side effects of direct oral anticoagulants.

Side effects 110

Side effects Medicine 110

World of DTC Marketing

AUGUST 29, 2022

The research showed that patients wanted to understand how the drug works and the potential side effects. Patients who experienced side one or more side effects were more likely to delay or stop treatment. Most physicians are trained in medicine and rely on their experiences to understand patients.

Side effects 203

Side effects Physicians Insurance Marketing 203

World of DTC Marketing

JULY 1, 2021

Some people complained about side effects, but there were many more questions about when to take medications and how to get help with costs. When it comes to side effects, the most read posts seem to be about side effects that impact “quality of life.” The answer to that is generally no.

Side effects 217

Side effects Doctors Prescription Media 217

Pharmaceutical Technology

APRIL 24, 2023

Traditional medicine refers to the knowledge, skills and practices that indigenous and different cultures use to maintain health, encompassing forms such as herbal medicine, Traditional Chinese Medicine (TCM) and acupuncture. Studying the behaviour of animals can aid in drug discovery research too.

Medicine 105

Medicine Side effects Healthcare Healthcare 105

European Pharmaceutical Review

NOVEMBER 14, 2022

Four medicines recommended for approval in the European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP)’s latest meeting included a biosimilar for osteoporosis and a novel COVID-19 vaccine. Indication extension recommendations for 11 medicines.

Medicine 98

Medicine Side effects Safety Pharmaceutical 98

European Pharmaceutical Review

JANUARY 11, 2024

A major limitation is that these drugs generally do not target the specific causes of neuropathic pain, and their efficacy is reduced when the underlying conditions, like nerve damage, cannot be treated effectively. What are the key current challenges in the development of pain medicines? Internet] NIH. cited 2024Jan].

Medicine 102

Medicine Pharmacology Management Side effects 102

European Pharmaceutical Review

JULY 20, 2022

Our research paper, which is being submitted for publication this summer, aims to create an evidence-based medicine (EBM) methodology that can assess this positive impact, to further help regulators determine appropriate risk minimisation measures. ketoconazole – an antifungal medicine. Supporting regulators.

Medicine 97

Medicine Safety Side effects Electronics 97

Pharmaceutical Technology

MAY 25, 2023

The Medicines and Healthcare products Regulatory Agency (MHRA) aims to launch a pilot genetic biobank that will gather patient data to associate drug-related adverse events to their genetic makeup. Side effects due to drugs are responsible for one in every 16 hospital admissions in the UK, based on the announcement.

Side effects 52

Side effects Medicine Recruitment Doctors 52

European Pharmaceutical Review

DECEMBER 15, 2022

The European Commission (EC) has expanded the marketing authorisation for Dupixent ® (dupilumab) in the European Union (EU), to treat adults with moderate-to-severe prurigo nodularis (PN) who are candidates for systemic therapy, making it the first and only targeted medicine for the condition in Europe and the US.

Medicine 98

Medicine Safety Side effects Patients 98

World of DTC Marketing

NOVEMBER 5, 2021

. “Obesity is multifactorial, meaning many factors are involved and go from genetics, lifestyle, mental health issues (such as trauma) to medication side effects,” says Dr. Viana, Clinical Director Yale Medicine Metabolic Health & Weight Loss Program.

Insurance 271

Insurance Side effects Medical Prescription 271

European Pharmaceutical Review

OCTOBER 31, 2022

The Pharmacovigilance Risk Assessment Committee (PRAC) , the European Medicines Agency (EMA)’s safety board, has confirmed it recommends the withdrawal of Marketing Authorisation Application (MAA) for amfepramone obesity medicines, to prevent more patients being at risk of serious side effects. Risks of amfepramones.

Side effects 98

Side effects Medicine Safety Marketing 98

World of DTC Marketing

JANUARY 7, 2022

Do you want your employer, or your insurance company, or anyone else to know you’re on anti-depressants, HIV medication, Viagra, or that you regularly get medicine for genital warts? When you use GoodRx, ALL that data regarding your prescription transaction is collected and stored. GoodRx employs people to dig into it analyze it.

Prescription 222

Prescription Insurance Side effects Medical 222

MedCity News

AUGUST 12, 2022

Liver complications are a known side effect risk of Zolgensma and other genetic medicines that are delivered by engineered viruses. The two deaths reported following treatment with Novartis’s Zolgensma mark the first fatal cases of acute liver failure associated with the gene therapy.

Side effects 98

Side effects Engineering Patients Medicine 98

MedCity News

OCTOBER 23, 2024

For patients who may be unable to afford the high cost of GLP-1 obesity drugs or are worried about the side effects, it’s important for healthcare providers to offer education on herbal alternatives and consider these as part of the broader treatment conversation. appeared first on MedCity News.

Side effects 121

Side effects Healthcare Provider Education Healthcare 121

World of DTC Marketing

JULY 5, 2022

Imagine a medicine that reduced the death rate of breast cancer and risk of recurrent breast cancer by 50% lowered the risks of colon cancer and type 2 diabetes by two-thirds, and those of heart disease, hypertension, and Alzheimer’s’ disease by 40%. But… Only 23% of Americans Get Enough Exercise.

Insurance 200

Insurance Doctors Pharma Side effects 200

European Pharmaceutical Review

NOVEMBER 21, 2024

Accessibility, as well as optimised nutrient and medicine release, are the driving forces behind modernising drug delivery. 2,3 In addition, the accessibility gap for treatment with pills can be widened by other factors such as the side effects of chemotherapy. Interested? Find out more by completing your details!

Side effects 98

Side effects Medicine Medical Pharmaceutical 98

World of DTC Marketing

DECEMBER 23, 2020

According to a study in the Journal for American Board of Family Medicine “respondents (76%) said they were likely to ask a health care provider about advertised drugs; 26% said they had already done so. What are the side effects? That belief is out the window. Today people go online to learn more about the drug.

Prescription 249

Prescription Doctors Side effects Marketing 249

European Pharmaceutical Review

MAY 30, 2024

Harnessing the properties of proline This innovative delivery approach, which utilises proline, an amino acid found in chicken feathers and skin tissue, could help to mitigate side effects associated with chemotherapy, such as hair loss and nerve damage, the research suggests.

Side effects 97

Side effects Transportation Medicine Pharmaceutical 97

European Pharmaceutical Review

JANUARY 30, 2023

In its first meeting of 2023, the European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) recommended four new medicines for approval, providing positive opinions for two type 2 diabetes drugs. Ultimately, this can lead to a progressive decrease in mobility and other severe impairments.

Side effects 96

Side effects Medicine Marketing Patients 96

MedCity News

JANUARY 30, 2024

AI can help by identifying the most effective treatment options and personalizing plans based on a patient’s unique characteristics and disease profile — potentially improving patient outcomes and reducing the risk of side effects.

Side effects 130

Side effects Ethics Medical Patients 130

World of DTC Marketing

JUNE 1, 2021

Kesselheim, a professor of medicine at Harvard Medical School via the Washington Post , says “the worst thing for people with Alzheimer’s would be to put out a product that doesn’t work.” SUMMARY: The FDA is coming under intense pressure to approve Biogen’s Alzheimer’s drug, but Aaron S.

FDA 187

FDA Side effects Patients Doctors 187

European Pharmaceutical Review

OCTOBER 9, 2023

The medicine takes over a week to break down in the body. This helps “to avoid dramatic spikes that worsen side effects, and dips that allow seizures to return. Among the results, the study revealed no signs of serious side effects such as heart problems, allergic reactions, or concerning skin discolorations.

Side effects 110

Side effects Recruitment Safety Medicine 110

European Pharmaceutical Review

SEPTEMBER 20, 2022

The Heads of Medicines Agencies (HMA) and the European Medicines Agency (EMA) have announced that biosimilar medicines authorised in the European Union (EU) can now be interchanged with their reference medicine or an equivalent biosimilar product. New regulatory guidance could lead to UK biosimilar boom.

Medicine 98

Medicine Side effects Safety Doctors 98

European Pharmaceutical Review

NOVEMBER 24, 2022

The first significant clinical report about the success of the CAR T therapy was published in Nature Medicine. Thus, effective CAR T treatment of this autoimmune disease may require a much lower dose that greatly reduces the problem of immunological side-effects.”.

Side effects 116

Side effects Medicine Doctors Patients 116

European Pharmaceutical Review

NOVEMBER 22, 2022

a China-based pharma company has announced it has received clearance for its Investigational New Drug (IND) application from the US Food and Drug Administration (FDA) to initiate clinical studies of T21, a 3D-printed medicine that can target specific segments in the colon to more safely deliver oral ulcerative colitis (UC) drugs.

Food and Drug Administration 111

Food and Drug Administration Side effects FDA Medicine 111

European Pharmaceutical Review

NOVEMBER 1, 2022

The committee advises that Cibinqo (abrocitinib), Jyseleca (filgotinib), Olumiant (baricitinib), Rinvoq (upadacitinib) and Xeljanz (tofacitinib), used for chronic inflammatory conditions, should have limited distribution to minimise risk of serious side effects such as cardiovascular diseases, blood clots, cancer and serious infections.

Side effects 98

Side effects Distribution Safety Patients 98

Clarivate

SEPTEMBER 25, 2024

A ‘magic bullet’ medicine that can cure a disease quickly and completely, [1] without deleterious side effects. [2] In 1897, Ehrlich proposed that certain cells expose a set of side chains on their surface, later termed ‘receptors’, which are associated with specific recognition. [3]

Medicine 59

Medicine Side effects Patients Pharmaceutical 59

Medgadget

MAY 3, 2023

These drugs are intended to stimulate immune cells in the vicinity of tumors to begin destroying tumor cells, but when delivered systemically they cause unacceptable dose limiting side-effects such as systemic inflammation. These particles are bottle-brush shaped, with the inactive drug being conjugated to the “brush backbone”.

Side effects 85

Side effects Engineering Training Medicine 85

European Pharmaceutical Review

NOVEMBER 18, 2022

It has been granted marketing authorisation by the Medicines and Healthcare Products Regulatory Agency (MHRA) in Great Britain. The most common side effects observed were initial insomnia, irritability and dyskinesia. The product, produced by biopharma company PTC Therapeutics, is approved for patients 18 months and over.

Side effects 126

Side effects Biopharma Safety Marketing 126

European Pharmaceutical Review

DECEMBER 7, 2022

The Medicines and Healthcare products Regulatory Agency (MHRA) has authorised Comirnaty ® , the Pfizer/BioNTech COVID-19 vaccine for infants and children aged six months to four years in Great Britain. The common, expected side effects were within expectations for a vaccine in this age group.

Food and Drug Administration 98

Food and Drug Administration Patients Side effects Medicine 98

European Pharmaceutical Review

NOVEMBER 2, 2022

The Phase I trial, published in Science Translational Medicine , involved building and applying a new generation of universal genome-edited T cells, a better solution to current chimeric antigen receptors (CAR) T- cell therapies which rely on collecting and engineering a patient’s own cells, an expensive and lengthy process.

Side effects 131

Side effects Engineering Consulting Manufacturing 131

European Pharmaceutical Review

NOVEMBER 3, 2023

The Medicines and Healthcare products Regulatory Agency (MHRA) has authorised Pfizer’s Litfulo (ritlecitinib) for treatment for severe alopecia areata in patients 12 years and older. A hard capsule medicine, Litfulo is recommended to be taken daily as one 50mg oral dose.

Food and Drug Administration 104

Food and Drug Administration Side effects Medicine Food 104

pharmaphorum

JULY 14, 2022

The antibody-drug conjugate (ADC) was turned down by NICE in draft guidance published earlier this year, leading to concerns of a disparity in access to the drug as the Scottish Medicines Consortium (SMC) had already cleared its use. The post NICE backs two new breast cancer drugs for NHS use appeared first on.

Side effects 104

Side effects Patients Medicine Government 104

Medgadget

FEBRUARY 15, 2023

Researchers at Wake Forest University School of Medicine have tested a closed-loop acoustic stimulation neurotechnology in its ability to treat insomnia. Simply taking sleeping tablets every night is not suitable for everyone, and can come with side-effects and even result in dependence.

Side effects 102

Side effects Medicine Leads 102

Medgadget

AUGUST 29, 2022

Used as a treatment for bipolar disorder and depression, lithium requires very accurate and sensitive dosing, with too little providing no therapeutic benefit but slightly too much potentially leading to unwanted side-effects. Another issue with the drug is the potential for poor patient compliance.

Side effects 115

Side effects Electronics Medical Patients 115

European Pharmaceutical Review

MARCH 8, 2023

“This is a highly effective compound that was well tolerated,” stated Dr Christie M. Ballantyne, Director of the Center for Metabolic Disease Prevention at Baylor College of Medicine in Houston and the study’s lead author. “MK-0616 MK-0616 could offer another potential option.

Side effects 98

Side effects Safety Medicine Patients 98